Enhancement of anti-HIV-1 activity by hot spot evolution of RANTES-derived peptides

Chemistry and Biology

Volumn 19, Issue 12, 2012, Pages 1579-1588

  Secchi, Massimiliano ^a   Longhi, Renato ^b   Vassena, Lia ^a   Sironi, Francesca ^a   Grzesiek, Stephan ^c   Lusso, Paolo ^a,d,e   Vangelista, Luca ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF BASEL   (Switzerland)

^d UNIVERSITY OF CAGLIARI   (Italy)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; RANTES; TRYPTOPHAN;

AMINO ACID SUBSTITUTION; ANTIVIRAL ACTIVITY; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG POTENCY; HOT SPOT EVOLUTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYDROPHOBICITY; MACROPHAGE; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTI-HIV AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINE CCL5; HIV INFECTIONS; HIV-1; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; MACROPHAGES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; RECEPTORS, CCR5; RECOMBINANT PROTEINS; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871569866     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2012.10.007     Document Type: Article

References (24)

1. C.C. Bleul, L. Wu, J.A. Hoxie, T.A. Springer, and C.R. Mackay The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes Proc. Natl. Acad. Sci. USA 94 1997 1925 1930
2. F. Cocchi, A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811 1815
3. P.M. Colman, and M.C. Lawrence The structural biology of type I viral membrane fusion Nat. Rev. Mol. Cell Biol. 4 2003 309 319
4. L. Duma, D. Häussinger, M. Rogowski, P. Lusso, and S. Grzesiek Recognition of RANTES by extracellular parts of the CCR5 receptor J. Mol. Biol. 365 2007 1063 1075
5. H. Gaertner, F. Cerini, J.M. Escola, G. Kuenzi, A. Melotti, R. Offord, I. Rossitto-Borlat, R. Nedellec, J. Salkowitz, and G. Gorochov Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide Proc. Natl. Acad. Sci. USA 105 2008 17706 17711
6. S.C. Garman, B.A. Wurzburg, S.S. Tarchevskaya, J.P. Kinet, and T.S. Jardetzky Structure of the Fc fragment of human IgE bound to its high-affinity receptor Fc epsilonRI α Nature 406 2000 259 266
7. B.L. Gilliam, D.J. Riedel, and R.R. Redfield Clinical use of CCR5 inhibitors in HIV and beyond J. Transl. Med. 9 Suppl 1 2011 S9
8. O. Hartley, and R.E. Offord Engineering chemokines to develop optimized HIV inhibitors Curr. Protein Pept. Sci. 6 2005 207 219
9. Y. Huang, W.A. Paxton, S.M. Wolinsky, A.U. Neumann, L. Zhang, T. He, S. Kang, D. Ceradini, Z. Jin, K. Yazdanbakhsh, and K. Kunstman The role of a mutant CCR5 allele in HIV-1 transmission and disease progression Nat. Med. 2 1996 1240 1243
10. M. Johnson, A.T. Coulton, M.A. Geeves, and D.P. Mulvihill Targeted amino-terminal acetylation of recombinant proteins in E. coli PLoS ONE 5 2010 e15801
11. J.M. Kilby, S. Hopkins, T.M. Venetta, B. DiMassimo, G.A. Cloud, J.Y. Lee, L. Alldredge, E. Hunter, D. Lambert, and D. Bolognesi Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry Nat. Med. 4 1998 1302 1307
12. P. Lusso, F. Cocchi, C. Balotta, P.D. Markham, A. Louie, P. Farci, R. Pal, R.C. Gallo, and M.S. Reitz Jr. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 J. Virol. 69 1995 3712 3720
13. P. Lusso HIV and the chemokine system: 10 years later EMBO J. 25 2006 447 456
14. P. Lusso, L. Vangelista, R. Cimbro, M. Secchi, F. Sironi, R. Longhi, M. Faiella, O. Maglio, and V. Pavone Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity FASEB J. 25 2011 1230 1243
15. V. Nardese, R. Longhi, S. Polo, F. Sironi, C. Arcelloni, R. Paroni, C. DeSantis, P. Sarmientos, M. Rizzi, and M. Bolognesi Structural determinants of CCR5 recognition and HIV-1 blockade in RANTES Nat. Struct. Biol. 8 2001 611 615
16. R. Nedellec, M. Coetzer, M.M. Lederman, R.E. Offord, O. Hartley, and D.E. Mosier "Resistance" to PSC-RANTES revisited: two mutations in human immunodeficiency virus type 1 HIV-1 SF162 or simian-human immunodeficiency virus SHIV SF162-p3 do not confer resistance J. Virol. 84 2010 5842 5845
17. R. Nedellec, M. Coetzer, M.M. Lederman, R.E. Offord, O. Hartley, and D.E. Mosier Resistance to the CCR5 inhibitor 5P12-RANTES requires a difficult evolution from CCR5 to CXCR4 coreceptor use PLoS ONE 6 2011 e22020
18. O. Nussbaum, C.C. Broder, and E.A. Berger Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation J. Virol. 68 1994 5411 5422
19. S. Polo, V. Nardese, C. De Santis, C. Arcelloni, R. Paroni, F. Sironi, A. Verani, M. Rizzi, M. Bolognesi, and P. Lusso Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation Eur. J. Immunol. 30 2000 3190 3198
20. Z.Y. Sun, K.J. Oh, M. Kim, J. Yu, V. Brusic, L. Song, Z. Qiao, J.H. Wang, G. Wagner, and E.L. Reinherz HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane Immunity 28 2008 52 63
21. L. Vangelista, R. Longhi, F. Sironi, V. Pavone, and P. Lusso Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity Biochem. Biophys. Res. Commun. 351 2006 664 668
22. L. Vangelista, M. Secchi, and P. Lusso Rational design of novel HIV-1 entry inhibitors by RANTES engineering Vaccine 26 2008 3008 3015
23. L. Vangelista, M. Secchi, X. Liu, A. Bachi, L. Jia, Q. Xu, and P. Lusso Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers Antimicrob. Agents Chemother. 54 2010 2994 3001
24. X. Wang, C. Watson, J.S. Sharp, T.M. Handel, and J.H. Prestegard Oligomeric structure of the chemokine CCL5/RANTES from NMR, MS, and SAXS data Structure 19 2011 1138 1148